SCHEMBL984446

SCHEMBL984446

CC(=O)N[C@H]1CC[C@H](NC(=O)c2c[nH]c3c(-c4cc(F)ccc4OCC4CC4)ncnc23)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 1/20 0.40
BRD4 O60885 1/20 0.39
CDK9 P50750 4/20 0.39
CASP3 P42574 1/20 0.39
CASP7 P55210 1/20 0.39
SCN8A Q9UQD0 1/20 0.37
SCN10A Q9Y5Y9 1/20 0.37
CDK1 P06493 3/20 0.37
CDK2 P24941 3/20 0.37
HTR2A P28223 2/20 0.36
DRD3 P35462 2/20 0.36
CYP4F2 P78329 1/20 0.36
CYP4A11 Q02928 1/20 0.36
CRHR1 P34998 1/20 0.36
ALDH1A1 P00352 1/20 0.36
KMT2A Q03164 1/20 0.36
CDK3 Q00526 2/20 0.36
CDK5 Q00535 2/20 0.36
LRRK2 Q5S007 2/20 0.36
GSK3A P49840 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL986391 0.94 CDK9 (0.41) BTKCDK9CASP3CASP7SCN8A
SCHEMBL985350 0.94 CDK9 (0.41) BTKCDK9CASP3CASP7SCN8A
SCHEMBL984898 0.92 GRIN1 (0.40) BTKBRD4SCN8ASCN10ACRHR1
SCHEMBL985596 0.92 SMYD3 (0.41) BTKBRD4SCN8ASCN10ACRHR1
SCHEMBL983050 0.91 BRD4 (0.37) BRD4CDK9SCN8ASCN10ACRHR1
SCHEMBL981978 0.91 NPY5R (0.38) BTKBRD4CDK9SCN8ASCN10A
Hydrochloric Acid SCHEMBL985170 0.91 SMYD3 (0.40) BTKBRD4SCN8ASCN10ACRHR1
SCHEMBL984745 0.91 BTK (0.39) BTKHTR2ADRD3CYP4F2CYP4A11
SCHEMBL982969 0.91 BRD4 (0.39) BRD4CDK9CASP3CASP7KMT2A
SCHEMBL984334 0.91 BTK (0.39) BTKBRD4CDK9SCN8ASCN10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-01-27 US claimed
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES PDE5A, PDE3A, PDE2A BTK 1977/4885BRD4 1299/4885CDK9 639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.